From the Department of Biochemistry and Molecular Biology, College of Basic Medicine, Key Laboratory of Medical Biotechnology of Hebei Province, Key Laboratory of Neural and Vascular Biology of Ministry of Education, Hebei Medical University, Shijiazhuang, PR China.
Circ Res. 2015 Sep 25;117(8):684-94. doi: 10.1161/CIRCRESAHA.115.306233. Epub 2015 Aug 19.
Vascular smooth muscle cell (VSMC) survival under stressful conditions is integral to promoting vascular repair, but facilitates plaque stability during the development of atherosclerosis. The cytoskeleton-associated smooth muscle (SM) 22α protein is involved in the regulation of VSMC phenotypes, whereas the pentose phosphate pathway plays an essential role in cell proliferation through the production of dihydronicotinamide adenine dinucleotide phosphate.
To identify the relationship between dihydronicotinamide adenine dinucleotide phosphate production and SM22α activity in the development and progression of vascular diseases.
We showed that the expression and activity of glucose-6-phosphate dehydrogenase (G6PD) are promoted in platelet-derived growth factor (PDGF)-BB-induced proliferative VSMCs. PDGF-BB induced G6PD membrane translocation and activation in an SM22α K21 ubiquitination-dependent manner. Specifically, the ubiquitinated SM22α interacted with G6PD and mediated G6PD membrane translocation. Furthermore, we found that tumor necrosis factor receptor-associated factor (TRAF) 6 mediated SM22α K21 ubiquitination in a K63-linked manner on PDGF-BB stimulation. Knockdown of TRAF6 decreased the membrane translocation and activity of G6PD, in parallel with reduced SM22α K21 ubiquitination. Elevated levels of activated G6PD consequent to PDGF-BB induction led to increased dihydronicotinamide adenine dinucleotide phosphate generation through stimulation of the pentose phosphate pathway, which enhanced VSMC viability and reduced apoptosis in vivo and in vitro via glutathione homeostasis.
We provide evidence that TRAF6-induced SM22α ubiquitination maintains VSMC survival through increased G6PD activity and dihydronicotinamide adenine dinucleotide phosphate production. The TRAF6-SM22α-G6PD pathway is a novel mechanism underlying the association between glucose metabolism and VSMC survival, which is beneficial for vascular repair after injury but facilitates atherosclerotic plaque stability.
血管平滑肌细胞(VSMC)在应激条件下的存活对于促进血管修复至关重要,但在动脉粥样硬化的发展过程中有利于斑块稳定。细胞骨架相关的平滑肌(SM)22α 蛋白参与调节 VSMC 表型,而戊糖磷酸途径通过产生二氢烟酰胺腺嘌呤二核苷酸磷酸(NADPH)在细胞增殖中发挥重要作用。
确定二氢烟酰胺腺嘌呤二核苷酸磷酸的产生与 SM22α 活性在血管疾病发展和进展中的关系。
我们表明,血小板衍生生长因子(PDGF)-BB 诱导的增殖性 VSMC 中葡萄糖-6-磷酸脱氢酶(G6PD)的表达和活性增加。PDGF-BB 诱导 G6PD 膜易位和激活,依赖于 SM22α K21 泛素化。具体而言,泛素化的 SM22α 与 G6PD 相互作用并介导 G6PD 膜易位。此外,我们发现肿瘤坏死因子受体相关因子(TRAF)6 在 PDGF-BB 刺激下以 K63 连接的方式介导 SM22α K21 泛素化。TRAF6 的敲低降低了 G6PD 的膜易位和活性,同时 SM22α K21 泛素化减少。PDGF-BB 诱导后激活的 G6PD 水平升高导致二氢烟酰胺腺嘌呤二核苷酸磷酸生成增加,通过刺激戊糖磷酸途径,增强了 VSMC 的活力,并在体内和体外通过谷胱甘肽稳态减少了细胞凋亡。
我们提供的证据表明,TRAF6 诱导的 SM22α 泛素化通过增加 G6PD 活性和二氢烟酰胺腺嘌呤二核苷酸磷酸生成来维持 VSMC 存活。TRAF6-SM22α-G6PD 途径是葡萄糖代谢与 VSMC 存活之间关联的一种新机制,有利于损伤后的血管修复,但有利于动脉粥样硬化斑块稳定。